Buscar resultados de ensayos clínicos
Ankylosis - 267 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation Condición:
|
Recruiting |
Nombre del estudio: A Multicenter Study to Evaluate the Efficacy and Safety of Different Doses of Bimekizumab in Subjects With Active Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-11-10 Intervenciones:
|
Completed |
Nombre del estudio: Relapse of Ankylosing Spondylitis Patients Withdrawal Etanercept After Clinical Remission: a Following-up Study Condición:
Fecha: 2016-09-23 Intervenciones: Drug: Etanercept Etanercept must be discontinued. Cotherapy with disease modifying anti-rheumatic drugs |
Not yet recruiting |
Nombre del estudio: Efficacy and Safety of IBI303 in Adult Patients With Active Ankylosing Spondylitis Condición: AS Fecha: 2016-08-29 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Clinical Trial to Evaluate Efficacy and Safety of Multiple Subcutaneous Injections of Various Doses of BCD-085 in Patients With Active Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-04-03 Intervenciones:
|
Recruiting |
Nombre del estudio: A Randomized, Double-blind, Placebo-controlled Multicenter Study of Secukinumab (AIN457) to Examine the Clinical Efficacy and the Nonsteroidal Anti-inflammatory Drug (NSAID)-Sparing Effect of Secukinumab Over 16 Weeks in Patients With Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-05-03 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Comparative Clinical Trial to Evaluate Efficacy and Safety of BCD-055 and Remicade® in Patients With Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-04-04 Intervenciones:
|
Recruiting |
Nombre del estudio: The Effect of NSAIDs Added to Anti-TNF Therapy Versus Anti-TNF Therapy Alone on Progression of Structural Damage in the Spine in Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-04-20 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Study of Efficacy and Safety of Secukinumab in Japanese Patients With Active Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-04-04 Intervenciones: Drug: secukinumab 150mg Baseline, 1, 2, 3, 4 week. After 4 week, administered every 4 weeks. |
Recruiting |
Nombre del estudio: Electroacupuncture for Relieving Pain in Ankylosing Spondylitis Condición: Ankylosing Spondylitis Fecha: 2016-02-24 Intervenciones: Device: Electroacupuncture |